TOP特許意匠商標
商標ウォッチ Twitter
公開日2023-12-20
公報種別公開国際商標公報
国際登録番号1757206
国際登録日2023-08-15
区分第5類(薬剤),第10類(医用機器),第36類(金融),第42類(科学・技術),第45類(法律)
商品役務Pharmaceuticals; pharmaceutical preparations for medical purposes excluding insecticides, disinfectants, sterilisers and swimming-pool additives for inhibiting algae; chemical preparations for pharmaceutical purposes; chemical reagents for medical use; biotechnological preparations for medical use; biological adjuvants for medical purposes; biochemical preparations for medical use; preparations for deodorizing air; deodorants for health/medical purposes; oils for medical purposes; air purifying preparations, pharmaceutical preparations for inhalers; none of the aforesaid goods being disinfectants or sanitary preparations, and not being adapted for use as disinfectant or sanitisers; none of the aforesaid being goods for use in diagnostics or for use in the examination, processing, transportation or testing of veterinary or medical samples.,Surgical and medical devices in the field of drug delivery systems, apparatus and instruments, excluding medical and veterinary sample containers, processing and analysis machines and test kits and personal protective equipment (PPE); inhalers for medical and pharmaceutical purposes; none of the aforesaid being goods for use in the examination, processing, transportation or testing of veterinary or medical samples or for use in diagnostics or in laboratory automation for diagnostic purposes, sample handling or sample preparation enabling and/or supporting medical, patient and veterinary data testing, processing and/or analysis.,Financing and equity investment services in the fields of pharmaceuticals, biotechnology life sciences; capital financing services in the fields of pharmaceuticals全 53 件を表示, biotechnology, life sciences; making direct and indirect investments in venture funds for the development and commercialization of products and management of product portfolios in the fields of pharmaceuticals, biotechnology, life sciences; investment services, namely, asset and investment acquisition, and development services; none of the aforesaid services being in relation to the examination, processing, transportation or testing services relating to veterinary or medical samples; none of the aforesaid services being in relation to diagnostic applications by means of medical samples or in the field of laboratory automation for diagnostic purposes by means of medical samples, specimen handling or sample preparation or being in the field of software and IT services for enabling and/or supporting medical, patient and veterinary sample data testing, processing and/or analysis.,Pharmaceutical research and development in the field of biotechnology, medical devices in the field of drug delivery systems, and life sciences; scientific research for clinical, medical and pharmaceutical purposes in the field of biotechnology, medical devices for drug delivery systems, and life sciences; research and development in the field of biotechnology, medical devices for drug delivery systems, and life sciences; pharmaceutical and medical device for drug delivery systems development in the field of biotechnology, medical devices, and life sciences; none of the aforesaid services being in relation to the examination, processing, transportation or testing services relating to veterinary or medical samples; none of the aforesaid services being in relation to diagnostic applications by means of medical samples or in the field of laboratory automation for diagnostic purposes by means of medical samples, specimen handling or sample preparation or being in the field of software and IT services for enabling and/or supporting medical, patient and veterinary sample data testing, processing and/or analysis.,Licensing of IP rights; licensing of IP in the field of pharmaceutical, biotechnology, life sciences; none of the aforesaid services being in relation to the examination, processing, transportation or testing services relating to veterinary or medical samples; none of the aforesaid services being in relation to diagnostic applications by means of medical samples or in the field of laboratory automation for diagnostic purposes by means of medical samples, specimen handling or sample preparation or being in the field of software and IT services for enabling and/or supporting medical, patient and veterinary sample data testing, processing and/or analysis.
基礎出願番号UK00003807641
基礎出願日2022-07-08
基礎出願国GB
出願人invoX Pharma Limited
OCRテキスト
OCRテキスト2invo
OCRについて
この商標をJ-PlatPatで参照する

関連商標

PTC Therapeutics, Inc.
nience
2か月前
Tulavi Therapeutics, Inc.
ALLAYNERVECAP
27日前
NOVARTIS AG
PENZEVO
27日前
NOVARTIS AG
POSMADIGM
27日前
Genmab A/S
FORTYSSIMO
27日前
JEOLLANAMDO
꿀잠상추
27日前
Beijing Darwin Biotech Co., LTD.
ALEETO
27日前
Kunakh Alim
GREESPI
23日前
NorrDia AB
27日前
FELCO INDUSTRIAL, SOCIEDAD ANONIMA DE CAPITAL VARIABLE
KING PROTEIN GOLD
27日前
Hanall Biopharma Co., Ltd.
HANALLBIOPHARMA
27日前
Antibiolabs
TAMRISA
27日前
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Lerentang Pharmaceutical Factory
27日前
VATECH CO., LTD.
vatech
27日前
Kura Oncology, Inc.
KURA CONCOLOGY
27日前
QUINCY BIOSCIENCE, LLC
27日前
Tulavi Therapeutics, Inc.
ALLAYGELCAP
27日前
NOVARTIS AG
GRATIFEXT
27日前
EATYX POLSKA sp. z o.o.
eatyx
27日前
Caliber Therapeutics, LLC
SirolimusEFR
27日前
Caliber Therapeutics, LLC
SOSTENOCEL
27日前
Kura Oncology, Inc.
KURAONCOLOGY
27日前
Glaxo Group Limited
KOTIMREE
27日前
Marius Pharmaceuticals LLC
KYZATREX
27日前
Novo Nordisk A/S
Konimba
27日前
Abbisko Therapeutics Co., Ltd.
In aliv
27日前
Axsome Therapeutics, Inc.
MYVELO
27日前
Capsugel Belgium NV
WAVE
27日前
THE HILSINGER COMPANY PARENT, LLC
THEDRYEYE -DRINK-
27日前
THE HILSINGER COMPANY PARENT, LLC
THEDRYEYEDRINK
27日前
Exact Sciences Corporation
cologuard plus
27日前
Exact Sciences Corporation
cologuardplus
27日前
Exact Sciences Corporation
☐cologuardplus
27日前
NOVARTIS AG
OMPLIZ
27日前
DAEWOONG PHARMACEUTICAL CO., LTD.
ENVLOPET
2か月前
CNEU MEDICAL s.r.o.
CarciReagent
1日前
続きを見る